Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Active Implantable Medical Devices Market, by Region, 2019-2029 (USD Billion)
1.2.2. Active Implantable Medical Devices Market, by Product, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Active Implantable Medical Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Active Implantable Medical Devices Market Dynamics
3.1. Active Implantable Medical Devices Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing Prevalence of Cardiovascular Diseases
3.1.1.2. Expanded Applications of Neurostimulators
3.1.2. Market Challenges
3.1.2.1. Dearth of Skilled Professionals
3.1.3. Market Opportunities
3.1.3.1. Technological Advancement in Active Implantable Medical Devices
Chapter 4. Global Active Implantable Medical Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Active Implantable Medical Devices Market, by Product
6.1. Market Snapshot
6.2. Global Active Implantable Medical Devices Market by Product, Performance – Potential Analysis
6.3. Global Active Implantable Medical Devices Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Active Implantable Medical Devices Market, Sub Segment Analysis
6.4.1. Implantable Cardioverter Defibrillators
6.4.2. Ventricular Assist Devices
6.4.3. Implantable Heart Monitors/Insertable Loop Recorders
6.4.4. Neurostimulators
6.4.5. Implantable Hearing Devices
Chapter 7. Global Active Implantable Medical Devices Market, Regional Analysis
7.1. Active Implantable Medical Devices Market, Regional Market Snapshot
7.2. North America Active Implantable Medical Devices Market
7.2.1. U.S. Active Implantable Medical Devices Market
7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
7.2.2. Canada Active Implantable Medical Devices Market
7.3. Europe Active Implantable Medical Devices Market Snapshot
7.3.1. U.K. Active Implantable Medical Devices Market
7.3.2. Germany Active Implantable Medical Devices Market
7.3.3. France Active Implantable Medical Devices Market
7.3.4. Spain Active Implantable Medical Devices Market
7.3.5. Italy Active Implantable Medical Devices Market
7.3.6. Rest of Europe Active Implantable Medical Devices Market
7.4. Asia-Pacific Active Implantable Medical Devices Market Snapshot
7.4.1. China Active Implantable Medical Devices Market
7.4.2. India Active Implantable Medical Devices Market
7.4.3. Japan Active Implantable Medical Devices Market
7.4.4. Australia Active Implantable Medical Devices Market
7.4.5. South Korea Active Implantable Medical Devices Market
7.4.6. Rest of Asia Pacific Active Implantable Medical Devices Market
7.5. Latin America Active Implantable Medical Devices Market Snapshot
7.5.1. Brazil Active Implantable Medical Devices Market
7.5.2. Mexico Active Implantable Medical Devices Market
7.5.3. Rest of Latin America Active Implantable Medical Devices Market
7.6. Rest of The World Active Implantable Medical Devices Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Medtronic plc (Ireland)
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Abbott Laboratories (U.S.)
8.2.3. Boston Scientific Corporation (U.S.)
8.2.4. BIOTRONIK SE & Co. KG (Germany)
8.2.5. LivaNova PLC (U.K.)
8.2.6. Cochlear Limited (Australia)
8.2.7. MED-EL (Austria)
8.2.8. Sonova Holding AG (Switzerland)
8.2.9. William Demant Holding A/S (Denmark)
8.2.10. Nurotron Biotechnology Co., Ltd. (China)
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
